Table 2 Symptoms reported by COVID-19 vs Influenza patients at time of hospital admission
Symptoms | COVID-19 (n = 96) | Influenza (n = 96) | p-value | ||
|---|---|---|---|---|---|
Days since symptom onset, median (IQR)a | 7 | (3–10) | 3 | (2–5) | < 0.001* |
General symptoms | |||||
Reduced general condition, malaise | 77 | (80.2%) | 72 | (75.0%) | 0.387 |
Fever, chills | 65 | (67.7%) | 62 | (64.6%) | 0.647 |
Fatigue | 31 | (32.3%) | 29 | (30.2%) | 0.755 |
Pain symptoms | |||||
Headache | 30 | (31.3%) | 41 | (42.7%) | 0.100 |
Limb pain, myalgia | 18 | (18.8%) | 24 | (25.0%) | 0.295 |
Arthralgia | 17 | (17.7%) | 18 | (18.8%) | 0.852 |
Back pain | 2 | (2.1%) | 5 | (5.2%) | 0.444 |
Chest pain | 10 | (10.4%) | 19 | (19.8%) | 0.070 |
Respiratory symptoms | |||||
Cough | 66 | (68.8%) | 73 | (76.0%) | 0.258 |
Dyspnea | 47 | (49.0%) | 31 | (32.3%) | 0.019* |
Sputum | 15 | (15.6%) | 26 | (27.1%) | 0.053 |
Coryza, nasal congestion | 7 | (7.3%) | 17 | (17.7%) | 0.029* |
Sore throat | 2 | (2.1%) | 12 | (12.5%) | 0.006* |
Gastrointestinal symptoms | |||||
Dysphagia | 0 | 5 | (5.2%) | 0.059 | |
Anorexia, weight loss | 23 | (24.0%) | 20 | (20.8%) | 0.604 |
Diarrhea | 18 | (18.8%) | 21 | (21.9%) | 0.590 |
Nausea, emesis | 14 | (14.6%) | 13 | (13.5%) | 0.836 |
Abdominal or stomach pain | 7 | (7.3%) | 7 | (7.3%) | 1.000 |
Neurological symptoms | |||||
Dizziness | 16 | (16.7%) | 23 | (24.0%) | 0.209 |
Confusion | 11 | (11.5%) | 9 | (9.4%) | 0.637 |
Syncope | 6 | (6.3%) | 7 | (7.3%) | 0.774 |
Dysarthria, paresthesia | 4 | (4.2%) | 7 | (7.3%) | 0.352 |
Somnolence | 4 | (4.2%) | 2 | (2.1%) | 0.683 |